Tc 99m votumumab

Drug Profile

Tc 99m votumumab

Alternative Names: HumaSPECT; Votumumab

Latest Information Update: 18 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Intracel Corporation
  • Class Monoclonal antibodies; Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Market Withdrawal Colorectal cancer

Most Recent Events

  • 18 May 2007 Discontinued - Phase-III for Colorectal cancer diagnosis in USA (IV)
  • 12 Sep 2003 KS Biomedix Holdings has been acquired by Xenova Group
  • 26 Feb 2003 Launched for Colorectal cancer diagnosis in European Union (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top